Today, Capital Rx, the health technology company changing the way prescription drugs are priced and patients are cared for, announced the promotion of Sara Izadi, PharmD, to Chief Clinical Officer. Dr. Izadi, a distinguished clinical leader, was one of Capital Rx’s first ten employees and has led the clinical team and clinical program initiatives since 2018.
In this role, Dr. Izadi will continue to ensure clinical service excellence, oversee quality management functions, and spearhead the development of novel clinical programs to provide the best possible outcomes for Capital Rx’s members.
“During my tenure at Capital Rx, I have witnessed the phenomenal growth of the company engendered by our innovative technology and cost-effective approach to pharmacy benefit management,” said Dr. Izadi. “I thank my team for their dedication to our mission and look forward to continuing to deliver optimal clinical outcomes for patients while balancing costs for plan sponsors.”
“Sara is a world-class clinical leader and a highly respected member of our leadership team at Capital Rx,” said AJ Loiacono, CEO of Capital Rx. “In her expanded role, Sara will further elevate our clinical programs as we progress into the next phase of our organization’s growth.”
Prior to joining Capital Rx, Dr. Izadi was a Senior Pharmacist and Program Lead at UnitedHealth Group and a Research/Clinical Pharmacist at Cedars-Sinai Medical Center. Dr. Izadi holds a Doctor of Pharmacy degree from the University of California – San Francisco.
Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!
